The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 352:98-100 January 6, 2005 Number 1
NextNext

Autoantibodies against Cardiac Troponins

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
To the Editor: Cardiac troponins are preferred markers of tissue injury in acute coronary syndromes. Their specificity and the fact that only very minute amounts or none are normally found in the circulation provide high clinical sensitivity and specificity even when cardiac lesions are small. The importance of cardiac troponins in identifying high-risk patients to receive active intervention is widely recognized.1

Troponins present substantial challenges with respect to immunoassays, however. They occur as various complexes or fragments and show other forms of heterogeneity.2 In addition, we recently reported3 that serum from many patients contains an interfering factor that prevents the . . . [Full Text of this Article]


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.